logo-loader
RNS
Metir PLC

Microsaic Systems - Update on Prospective Acquisition, Fundraise & GM

RNS Number : 4963X
Microsaic Systems plc
20 December 2023
 

20 December 2023

Microsaic Systems plc

("Microsaic" or the "Company")

 

Prospective Acquisition and Revised Fundraising,
General Meeting and Timetable, Current Funding

 

 

Capitalised terms in this announcement carry the same meaning

as in the RNS dated 14 December 2023 unless the context indicates otherwise

 

 

Prospective Acquisition

 

Further to the Company's prior announcement on 14 December 2023, Microsaic confirms that it has today entered into an Exclusivity Agreement with DeepVerge plc ("DeepVerge") granting Microsaic a period of exclusivity in respect of the potential purchase of certain assets of DeepVerge's Modern Water business ("Exclusivity Period"). The assets broadly comprise equipment for the laboratory-based manufacturing of bio-reagents used in related water testing equipment, currently based at DeepVerge's York laboratory, and include all IP and rights to the related testing equipment including LX, FX and Continuous Toxic Measuring (CTM) machines and water membrane technology (the "Business").

 

The granting of the Exclusivity Period follows the making by Microsaic to DeepVerge of an indicative outline proposal to purchase the Business for a payment of £100,000 in cash, which would be payable to DeepVerge on completion (the "Proposal").

The Exclusivity Period runs until the earlier of (a) 16 January 2024, (b) the signature of a legally binding sale and purchase agreement between Microsaic and DeepVerge for the Business (the "Transaction"), or (c) withdrawal of the Proposal by Microsaic.

No consideration has been paid by Microsiac for the granting of the Exclusivity Period.

During the Exclusivity Period, DeepVerge shall not solicit, advertise, market or enter any other negotiations, arrangements, options or agreements with any third parties relating to the sale of the Business and shall not agree to complete, or complete, the Transaction with any party other than with Microsaic.

The Exclusivity Period may be extended at the discretion of DeepVerge for a further period to enable the Transaction to be finalised.

The Exclusivity Period is designed to provide Microsaic with time to conclude its due diligence, obtain binding commitments for its Revised Fundraising (as defined in the Company's RNS dated 14 December 2023, including working capital for the expanded business and the consideration for the Transaction), and to negotiate and sign a detailed sale and purchase agreement with DeepVerge. There is no guarantee that the Transaction will occur, or that the outline terms indicated in the Proposal will be those on which a binding agreement is signed.

Microsaic director Dr Nigel Burton is also a director of DeepVerge. Robert (Bob) Moore is the only independent director of Microsaic with regard to the Transaction. Given his conflict of interest, Dr Burton is not involved in the consideration of the Transaction for either Microsaic.

Microsaic anticipates that the Transaction, if entered into, would constitute a related party transaction for the Company under the AIM Rules for Companies (the "AIM Rules") and would therefore require treatment in accordance with AIM Rule 13 (related party transactions) [and as a substantial transaction in accordance with AIM Rule 15].  

 

Revised Fundraising, General Meeting and Timetable

Funding for the Transaction is expected to be procured via the Revised Fundraising. As previously indicated, the Company yesterday adjourned its General Meeting which has been convened to enable the Company to undertake the Share Capital Re-organisation, amend its Articles and obtain the necessary authorities from shareholders to implement its fundraising requirements.

Microsaic will shortly provide an update to Shareholders in relation to the revised date for the General Meeting, and the expected timetable of principal events relating to the Revised Fundraising and the proposed Acquisition.

 

Current Funding

Microsaic has recently realised a small amount of cash from the sale of tangible assets, and as a result has sufficient cash runway for the duration of the Exclusivity Period, during which it also expects to conclude the Revised Fundraising as well as the Transaction. Completion remains subject, inter alia, to the restoration of the Company's shares to admission to trading on AIM, and other factors as described in the announcement of 4 December 2023.

 

Further updates will be provided as appropriate.

 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain

 

Enquiries:

Microsaic Systems plc                                                                                   +44 (0)1483 751 577

Bob Moore, Acting Executive Chairman

 

Singer Capital Markets (Nominated Adviser)                                     +44 (0)20 7496 3000

Aubrey Powell / Angus Campbell / Oliver Platts

 

Turner Pope Investments (TPI) Limited (Broker)                                               +44 (0) 20 3657 0050

Andy Thacker / James Pope

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBDBDDCBDDGXG
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Holding(s) in Company

1 week, 1 day ago

Holding(s) in Company

1 week, 1 day ago

Holding(s) in Company

1 week, 1 day ago

Holding(s) in Company

1 week, 1 day ago

Holding(s) in Company

1 week, 2 days ago

Holding(s) in Company

1 week, 3 days ago

Holding(s) in Company

1 week, 3 days ago

Holding(s) in Company

1 week, 6 days ago

5 min read